Briax 20 Mg

Briax 20 mg is a medication containing the active ingredient Apixaban, which is an anticoagulant (blood thinner) used to reduce the risk of blood clots and stroke in patients with conditions like atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). Apixaban works by inhibiting Factor Xa, an enzyme involved in the clotting process, thus helping to prevent the formation of dangerous blood clots.

Briax 20 mg is often prescribed to patients who are at higher risk of clot-related conditions, including those recovering from certain surgeries such as hip or knee replacements. It is taken orally, typically twice daily, and its dosage may vary depending on the specific condition being treated and the patient’s medical history.

Patients using Briax need to follow their doctor’s instructions carefully, as it can increase the risk of bleeding. It’s important to inform healthcare providers of any other medications being taken to avoid drug interactions, and patients should be monitored for any signs of excessive bleeding or unusual bruising during treatment.